Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ANTXANTX
13 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in AN2 THERAPEUTICS INC

Qube Research & Technologies Ltd previously held 0 shares of ANTX (AN2 THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$156,069

Total Shares Change

-18,361

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$4.84
0
2026-Q1
Increased
24,168
+137.3%
$82,6550.0%$1.06
35
2025-Q4
Unchanged
10,184
0.0%
$11,6100.0%$1.08
0
2025-Q3
Unchanged
10,184
0.0%
$12,9340.0%$1.28
0
2025-Q2
Unchanged
10,184
0.0%
$10,7950.0%$1.08
0
2025-Q1
Decreased
10,184
-0.0%
$13,8500.0%$1.39
0
2024-Q4
New
10,185
-
$14,0550.0%$1.41
27
2024-Q3
Exited
0
-100.0%
$00.0%$1.06
0
2024-Q2
Decreased
10,186
-79.8%
$21,9000.0%$2.15
0
2024-Q1
Decreased
50,365
-30.3%
$163,6860.0%$3.25
0
2023-Q4
New
72,208
-
$1.5M0.0%$20.49
35
2023-Q3
Exited
0
-100.0%
$00.0%$16.08
0
2023-Q2
New
18,361
-
$156,0690.0%$8.40
31

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used